The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's also this paper looking at apoe4 in nigerian population cholesterol aoe genotype and alzheimer's in the nigerian yoruba as you can see here there was a significant interaction between cholesterol apoe4 and the risk of alzheimer's disease in the aruba a population that has lower cholesterol levels lower incidence rates of a.d compared to african populations and they found that apoe4 was protective
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
increasing levels of cholesterol and ldl were associated with an increased risk of alzheimer's disease disease in individuals without the apoe4 allele but not in those with apoe4